<DOC>
	<DOCNO>NCT01671839</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness Cabochon System improvement appearance cellulite .</brief_summary>
	<brief_title>Study Cabochon System Improvement Appearance Cellulite</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>Female , age 1855 moderate severe cellulite BMI le 35 try cellulite treatment 12M followup cellulite treatment thighs buttock last 90 day prior liposuction thigh buttock Greater 10 % increase decrease body weight within past 6 month evidence active infection fever &gt; 38C current recent smoker history hypertension , diabetes hypoglycemia history coagulopathy ( y ) and/or anticoagulant medication history cardiopathy pneumopathy history severe anemia atrophic scar , history atrophic scar keloid take within 14 day treatment : NSAIDs ( e.g . aspirin , ibuprofen , naproxen ) Vitamin E , dietary supplement ( e.g . Gingko Biloba , willow bark ) Herbal Teas Subject pregnant lactating For Extended FollowUp follow apply : Subject enrol treated CP011004 study Pivotal Study Cabochon System Improvement Appearance Cellulite Subject understand accepts obligation try receive cellulite treatment 3 year followup Subject undergone inject drug , energybased device , minimallyinvasive invasive procedure contour cellulite buttock thigh since 12 month study followup visit . Subject use skin care product ( e.g . cream ) improvement cellulite within 1 month prior followup visit .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>